Distinguishing lung tumours from normal lung based on a small set of genes

Lung Cancer

Volumn 55, Issue 2, 2007, Pages 157-164

  Dracheva, Tatiana ^a   Philip, Reena ^b   Xiao, Wenming ^b   Gee, Alexander G ^c   McCarthy, John ^c   Yang, Ping ^d   Wang, Yue ^b   Dong, Gang ^b   Yang, Hongjun ^b   Jen, Jin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MetriGenix US Inc   (United States)

^c AnVil Incorporated   (United States)

^d Mayo Clinic College of Medicine   (United States)

Author keywords

Cancer detection; Class prediction; Expression profiling; Flow Thru Chip ; Gene chip; Non small cell lung cancer

Indexed keywords

COMPLEMENTARY DNA; RNA;

ANALYTIC METHOD; ARTICLE; BIOCHIP; CANCER DIAGNOSIS; CANCER SCREENING; CANCER TISSUE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS;

CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33846055972     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.10.025     Document Type: Article

References (33)

1. Velculescu V.E., Zhang L., Vogelstein B., and Kinzler K.W. Serial analysis of gene expression. Science 270 (1995) 484-487
2. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2 (2002) 210-219
3. Rosenwald A., Wright G., Chan W.C., Connors J.M., Campo E., Fisher R.I., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346 (2002) 1937-1947
4. Holtkamp N., Reuss D.E., Atallah I., Kuban R.J., Hartman C., Maunter V.F., et al. Subclassification of nerve sheath tumors by gene expression profiling. Brain Pathol 14 (2004) 258-264
5. Murakawa K., Tada M., Takada M., Tamoto E., Shindoh G., Teramoto K., et al. Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res 122 (2004) 184-194
6. Iizuka N., Oka M., Yamada-Okabe H., Nishida M., Maeda Y., Mori N., et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361 (2003) 923-929
7. Ye Q.H., Qin L.X., Forgues M., He P., Kim J.W., Peng A.C., et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9 (2003) 416-423
8. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
9. Hibi K., Liu Q., Beaudry G.A., Madden S.L., Westra W.H., Wehage S.L., et al. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res 58 (1998) 5690-5694
10. Nacht M., Dracheva T., Gao Y., Fujii T., Chen Y., Player A., et al. Molecular characteristics of non-small cell lung cancer. PNAS 98 (2001) 15203-15208
11. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci 98 (2001) 13790-13795
12. Meyerson M., Franklin W.A., and Kelley M.J. Molecular classification and molecular genetics of human lung cancers. Semin Oncol 31 (2004) 4-19
13. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8 (2002) 816-824
14. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
15. Johnson R.A., and Wichern D.W. Applied multivariate statistical analysis (1982), Prentice-Hall, Englewood Cliffs, New Jersey
16. Gordon A.D. Classification (1999), Chapman and Hall/CRC Press, London
17. Radmacher M.D., Mcshane L.M., and Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol 9 (2002) 505-511
18. McCarthy J.F., Marx K.A., Hoffman P.E., Gee A.G., O'Neil P., Ujwal M.L., et al. Applications of machine learning and high-dimensional visualization in cancer detection, diagnosis, and management. Ann NY Acad Sci 1020 (2004) 239-262
19. Witten I.H., and Frank E. Data mining: practical machine learning tools and techniques with java implementation (2000), Morgan Kaufmann, San Francisco, California
20. Cheek B.J., Steel A.B., Torres M.P., Yu Y.Y., and Yang H. Chemiluminescence detection for hybridization assays on the flow-thru chip, a three-dimensional microchannel biochip. Anal Chem 73 (2001) 5777-5783
21. Lockhart D.J., Dong H., Byrne M.C., Follettie M.T., Gallo M.V., Chee M.S., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14 (1996) 1675-1680
22. Lucke C.D., Philpott A., Metcalfe J.C., Thompson A.M., Hughes-Davies L., Kemp P.R., et al. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. Cancer Res 61 (2001) 482-485
23. Yuan B.Z., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J.E., et al. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 22 (2003) pp. 445-5
24. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
25. Douglas D.B., Akiyama Y., Carraway H., Belinsky S.A., Esteller M., Gabrielson E., et al. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Cancer Res 64 (2004) 1611-1620
26. Oue N., Hamai Y., Mitani Y., Matsumura S., Oshimo Y., Aung P.P., et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64 (2004) 2397-2405
27. Mori Y., Sato F., Selaru F.M., Olaru A., Perry K., Kimos M.C., et al. Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. Cancer Res 62 (2002) 3641-3645
28. Zeng S.X., Dai M.S., Keller D.M., and Lu H. SSRP1 functions as a co-activator of the transcriptional activator p63. Embo J 21 (2002) 5487-5497
29. Tomizawa Y., Sekido Y., Kondo M., Gao B., Yokota J., Roche J., et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 98 (2001) 13954-13959
30. Yuan B.Z., Jefferson A.M., Baldwin K.T., Thorgeirsson S.S., Popescu N.C., and Reynolds S.H. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23 (2004) 1405-1411
31. Carboni G.L., Gao B., Nishizaki M., Xu K., Minna J.D., Roth J.A., et al. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene 22 (2003) 615-626
32. Guo L., Ma Y., Ward R., Castranova V., Shi X., and Qian Y. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin Cancer Res 12 (2006) 3344-3354
33. Raponi M., Zhang Y., Yu J., Chen G., Lee G., Taylor J.M., et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 66 (2006) 7466-7472